ObvioHealth is at DTx Alliance 2023

We’ll be attending DTx Alliance Summit! Connect with us to learn more about optimizing patient-centric clinical trials—with best-in-class digital tools that drive efficiency and generate stronger evidence.

Schedule a Meeting

Meet Our DHT Expert

Do you want to identify the best DCT solution for your DTx trial? ObvioHealth’s tech-savvy clinical team can help you design and execute a study that will seamlessly integrate your device with our app to enhance patient centricity, boost engagement, and improve data accuracy. And, our virtual site team can ensure that patients are monitored in near real time for compliance and safety.  

Schedule a meeting now with our digital health tech expert, Michael Skinner, to get the conversation started.

Michael Skinner

Executive Director, Strategic Accounts

Michael has spent 15 years bringing technology and data solutions to the life sciences industry. He has a passion for digital innovation and is an operational strategist for decentralized and patient-centric technologies.

About ObvioHealth

ObvioHealth is an end-to-end virtual research organization (VRO), combining the clinical excellence of the best CROs with pioneering digital health technology. We optimize clinical trials at every stage and touchpoint—streamlining the process for patients, sites, and sponsors alike.  

  • ObvioGo® DCT platform and app incorporates best-in-class digital instruments, AI, and machine learning to deliver more robust clinical outcomes with less burden on all stakeholders.
  • ObvioGo seamlessly integrates with your DTx via API to capture outcomes as well as usage data, minimizing bias and barriers to compliance to deliver stronger evidence.
  • Virtual site teams monitor patient safety and compliance in real time while providing on-demand, personalized support that keeps patients motivated and engaged.
  • We know digital! ObvioHealth’s DCT strategists have run DTx studies end to end across multiple therapeutic areas. We offer the same services as a traditional CRO, optimized for a decentralized and digital environment.